Skip to content

Clinical trials

Lung Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: France Clear all

386 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20024
20033
20045
20058
20067
20077
20086
20098
20105
201111
201219
201312
201414
201520
201616
201714
201814
201915
202019
202133
202224
202319
202430
202532
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed184
Recruiting89
Unknown status36
Active, not recruiting32
Terminated27
Not yet recruiting13
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris19
Hospices Civils de Lyon16
Novartis Pharmaceuticals13
AstraZeneca12
Bristol-Myers Squibb12
European Organisation for Research and Treatment of Cancer - EORTC12
Eli Lilly and Company8
Gustave Roussy, Cancer Campus, Grand Paris8
University Hospital, Brest8
Intergroupe Francophone de Cancerologie Thoracique7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms386
Carcinoma, Non-Small-Cell Lung156
Neoplasms55
Breast Neoplasms48
Neoplasm Metastasis33
Colorectal Neoplasms29
Head and Neck Neoplasms26
Colonic Neoplasms22
Ovarian Neoplasms19
Prostatic Neoplasms19

Trials

Showing 51 to 75 of 386. Each trial links to its page on Pharma Observatory.

286 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.